2025-07-26 - Analysis Report
Okay, here's a report summarizing the provided information on Eli Lilly and Co (LLY), formatted as requested:

## Eli Lilly and Co (LLY) Stock Analysis

**Ticker:** LLY
**Company Name:** Eli Lilly and Co
**Description:** A global pharmaceutical company engaged in the discovery, development, manufacturing, and marketing of pharmaceutical products.

### 1. Performance vs. S&P 500 (VOO)

*   **LLY Cumulative Return:** 249.28%
*   **VOO Cumulative Return:** 99.66%
*   **Absolute Divergence:** 146.7
*   **Relative Divergence:** 51.3 (Indicates LLY's performance is in the upper half of its historical divergence range from VOO)

**Analysis:** LLY has significantly outperformed the S&P 500 (VOO) over the period. The relative divergence suggests that this outperformance is strong compared to its historical trend, but not at the extreme upper end.

**Alpha/Beta Analysis Table:**

| Year       | CAGR   | MDD    | Alpha  | Beta  | Cap(B) |
|------------|--------|--------|--------|-------|--------|
| 2015-2017  | 10.0%  | 56.3%  | -19.0% | 0.0   | 75.8   |
| 2016-2018  | 39.0%  | 58.6%  | 21.0%  | -0.1  | 103.9  |
| 2017-2019  | 50.0%  | 58.6%  | 20.0%  | 0.3   | 118.0  |
| 2018-2020  | 52.0%  | 58.6%  | 33.0%  | 0.1   | 151.6  |
| 2019-2021  | 106.0% | 60.6%  | 57.0%  | 0.2   | 248.0  |
| 2020-2022  | 98.0%  | 64.8%  | 96.0%  | 0.2   | 328.4  |
| 2021-2023  | 133.0% | 64.8%  | 115.0% | 0.3   | 523.3  |
| 2022-2024  | 150.0% | 72.2%  | 124.0% | 0.2   | 693.0  |
| 2023-2025  | 102.0% | 76.8%  | 51.0%  | 0.2   | 729.6  |

**Table Analysis:**

*   **CAGR:**  The Compounded Average Growth Rate shows strong growth, especially in recent years.
*   **MDD:** The Maximum Drawdown indicates the largest peak-to-trough decline during the period, providing a measure of downside risk.  The MDD values are significant, indicating relatively high volatility at times.
*   **Alpha:**  Positive alpha values consistently suggest that LLY has outperformed its benchmark (S&P 500) after accounting for market risk. The alpha has been particularly high in recent periods.
*   **Beta:** Beta values are generally low, indicating that LLY's price is not strongly correlated with the overall market.
*   **Market Cap:** Shows the significant increase in market capitalization over time.

### 2. Recent Price Action

*   **Current Price:** 812.69
*   **Previous Close:** 805.43
*   **Change:** 0.9%
*   **5-day Moving Average:** 791.126
*   **20-day Moving Average:** 783.2025
*   **60-day Moving Average:** 773.5277

**Analysis:**  The current price is above all three moving averages, indicating an upward trend. The price increased from the previous close which reflect recent news.

### 3. Technical Indicators and Outlook

*   **Market Risk Indicator (MRI):** 0.3301 (Low Risk)
*   **RSI:** 61.67 (Approaching overbought territory)
*   **PPO:** 0.3493 (Positive, indicating an uptrend)
*   **Hybrid Signal:** Cash_3%_Buy 80% of cash (60 shares - Caution - MRI:0.33)
*   **Delta_Previous_Relative_Divergence (20-day):** -1.7 (Indicates a short-term decrease in relative divergence)
*   **Expected Return (%):** 153.0% (Long-term, relative to S&P 500)

**Analysis:**  The MRI suggests a low-risk environment. The RSI is approaching overbought, which could indicate a potential pullback. The Hybrid Signal recommends a cautious buying strategy. The recent decrease in relative divergence suggests a possible short-term weakening of LLY's outperformance relative to the S&P 500.  The high expected return suggests strong long-term growth potential compared to the market.

### 4. Recent News & Significant Events

*   **2025-07-24:** Major business developments, regulatory changes, or market events.
*   **2025-07-23:** Analyst discussions on performance, industry trends, and global economic factors.
*   **2025-07-25:** Notable stock volatility due to recent news, earnings, or executive actions.
*   **2025-07-26:** Market expert advise monitoring recent news and company announcements.

**Analysis:** Recent news indicates potential volatility and important developments that require close monitoring. These events could be catalysts for further price movement.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-05-01 | 3.07 | 12.73 B$   |
| 2024-10-30 | 1.08 | 11.44 B$   |
| 2024-08-08 | 3.29 | 11.30 B$   |
| 2024-04-30 | 2.49 | 8.77 B$    |
| 2025-05-01 | 2.49 | 8.77 B$    |

**Analysis:** Earnings per Share (EPS) and revenue have generally shown an increasing trend, indicating strong financial performance. The recent earnings release will be of interest for current and future growth expectations.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-03-31 | $12.73B   | 82.53%        |
| 2024-12-31 | $13.53B   | 82.24%        |
| 2024-09-30 | $11.44B   | 81.02%        |
| 2024-06-30 | $11.30B   | 80.80%        |
| 2024-03-31 | $8.77B    | 80.91%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE     |
|------------|-----------|---------|
| 2025-03-31 | $15.76B   | 17.50%  |
| 2024-12-31 | $14.19B   | 31.07%  |
| 2024-09-30 | $14.24B   | 6.81%   |
| 2024-06-30 | $13.56B   | 21.88%  |
| 2024-03-31 | $12.81B   | 17.51%  |

**Analysis:**

*   **Revenue:** Shows a strong upward trend in recent quarters.
*   **Profit Margin:**  Extremely high and consistent, demonstrating excellent operational efficiency.
*   **Equity:** Increasing equity indicates the company is building its asset base.
*   **ROE:**  Return on Equity is volatile but generally strong, suggesting good profitability relative to shareholders' equity.

### 7. Overall Summary

Eli Lilly and Co (LLY) exhibits strong financial performance, significant outperformance compared to the S&P 500, and favorable growth prospects. The company demonstrates high revenue, very high profit margins, and generally good ROE. Technical indicators suggest the stock is in an uptrend, and the long-term expected return is very attractive. However, recent news and a high RSI point to potential short-term volatility and the need for careful monitoring. The Hybrid Signal recommending a "Cash_3%_Buy" approach reflects this cautious outlook. Investors should consider recent events and monitor earnings releases closely.
